64 Results for "

insulin/IGF-1 receptor

" in MedChemExpress (MCE) Product Catalog:
Products (64)

64 Results for "insulin/IGF-1 receptor" in MCE Product Catalog:

52
52 Publications Verification
Cat. No.: HY-10191
CAS No.: 867160-71-2
Purity:  99.87%
Synonyms: OSI-906
Target:  

IGF-1R Insulin Receptor

Research Areas:  

Endocrinology Cancer

Linsitinib (OSI-906) is a potent, selective and orally bioavailable dual inhibitor of the IGF-1 receptor and insulin receptor (IR) with IC50s of 35 and 75 nM, respectively .
loading...
    loading...
31
31 Cited Publications
Cat. No.: HY-15494
CAS No.: 477-47-4
Purity:  99.85%
Synonyms: AXL1717; Picropodophyllotoxin; PPP
Picropodophyllin (AXL1717) is a selective insulin-like growth factor-1 receptor (IGF-1R) inhibitor with an IC50 of 1 nM.
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-50866
CAS No.: 475489-16-8
Synonyms: AEW541
Research Areas:  

Endocrinology Cancer

NVP-AEW541 (AEW541 ) is an orally active inhibitor of the insulin-like growth factor 1 receptor (IGF-1R) with an IC50 value of 0.15 μM. NVP-AEW541 also inhibits InsR, IC50 with a value of 0.14 μM. NVP-AEW541 has antitumor activity .
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-13203
CAS No.: 761437-28-9
Purity:  99.77%
Synonyms: TAE226
Research Areas:  

Endocrinology Cancer

NVP-TAE 226 (TAE226) is a potent and ATP-competitive dual FAK and IGF-1R inhibitor with IC50s of 5.5 nM and 140 nM, respectively. NVP-TAE 226 (TAE226) also effectively inhibits Pyk2 and insulin receptor (InsR) with IC50s of 3.5 nM and 44 nM, respectively .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-10524
CAS No.: 1089283-49-7
Purity:  99.03%
Research Areas:  

Endocrinology Cancer

GSK1904529A is a potent, selective, orally active, and ATP-competitive inhibitor of insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR), with IC50s of 27 and 25 nM, respectively. GSK1904529A shows poor activity (IC50>1 μM) in 45 other serine/threonine and tyrosine kinases. GSK1904529A exhibits anti-tumor activity .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-10262
CAS No.: 468740-43-4
Purity:  99.83%
Research Areas:  

Endocrinology Cancer

BMS-536924 is an orally active, competitive and selective insulin-like growth factor receptor (IGF-1R) kinase and insulin receptor (IR) inhibitor with IC50s of 100 nM and 73 nM, respectively. BMS-536924 has anti-cancer activity .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-10199A
CAS No.: 159634-47-6
Purity:  98.52%
Synonyms: MK-677 free base; MK-0677 free base
Ibutamoren (MK-677 free base; MK-0677 free base) is an orally active non-peptide growth hormone secretagogue receptor agonist. Ibutamoren activates signal cascades by mimicking endogenous ligands, triggers pulsatile release of growth hormone from the pituitary gland, and increases serum levels of IGF-1 and insulin-like growth factor-binding protein 3. Ibutamoren not only increases the frequency of growth hormone pulses in male individuals, but also promotes elevated bone formation markers in female individuals with postmenopausal osteoporosis. The combination of Ibutamoren with Alendronate sodium hydrate (HY-11101) significantly increases bone mineral density at the femoral neck. However, Ibutamoren may cause mild, reversible adverse reactions such as increased appetite, fluid retention, and elevated fasting blood glucose. Ibutamoren has been widely used in studies related to idiopathic growth hormone deficiency, sarcopenia, Alzheimer's disease, and osteoporosis .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-10252
CAS No.: 475488-23-4
Purity:  99.30%
Synonyms: ADW742; GSK 552602A; ADW
Research Areas:  

Endocrinology Cancer

NVP-ADW742 (ADW742) is an orally active, selective IGF-1R tyrosine kinase inhibitor with an IC50 of 0.17 μM. NVP-ADW742 inhibits insulin receptor (InsR) with an IC50 of 2.8 μM. NVP-ADW742 induces pleiotropic antiproliferative/proapoptotic biologic sequelae in tumor cells .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B0025
CAS No.: 83480-29-9
Voglibose is an orally active alpha-glucosidase inhibitor that prevents the development of colorectal precancerous lesions induced by obesity and diabetes. Voglibose reduces oxidative stress in an inflammatory environment and inhibits the insulin-like growth factor/insulin-like growth factor-1 receptor (IGF/IGF-1R) functional axis .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P78723
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: IGF1R; IGF-I receptor; insulin Like Growth Factor 1 receptor; MGC18216; insulin-Like Growth Factor 1 receptor; insulin-Like Growth Factor I receptor; JTK13; receptor Protein-Tyrosine Kinase; CD221; Tyrosine-Protein Kinase receptor; IGFIR; CD221 Antigen; IGFR; IGF1R Protein
Species:  
Mouse
Source:  
HEK293
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P99294
CAS No.: 905703-97-1
Synonyms: AMG 479; Human Anti-IGF1R Recombinant Antibody

Target:  

IGF-1R

Research Areas:  

Cancer

Ganitumab (AMG 479) is a recombinant human monoclonal antibody to the human type 1 insulin-like growth factor receptor (IGF1R). Ganitumab recognizes murine IGF1R with sub-nanomolar affinity (KD=0.22 nM) and inhibits the interaction of murine IGF1R with IGF1 and IGF2. Ganitumab can be used in research of cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-135680
CAS No.: 1094048-77-7
Purity:  98.03%
Synonyms: I-OMe-AG 538
Target:  

IGF-1R

Research Areas:  

Metabolic Disease Cancer

I-OMe-Tyrphostin AG 538 (I-OMe-AG 538) is a specific inhibitor of IGF-1R (insulin-like growth factor-1 receptor tyrosine kinase). I-OMe-Tyrphostin AG 538 inhibits IGF-1R-mediated signaling and is preferentially cytotoxic to nutrient-deprived PANC1 cells.?I-OMe-Tyrphostin AG 538 is an ATP-competitive inhibitor of phosphatidylinositol-5-phosphate 4-kinase α (PI5P4Kα), with an IC50?of 1 μM .
loading...
    loading...
Cat. No.: HY-P99197
CAS No.: 943453-46-1
Synonyms: CP-751871

Target:  

IGF-1R

Research Areas:  

Cancer

Figitumumab (CP-751871) is a potent and fully human monoclonal anti–insulin-like growth factor 1 receptor (IGF1R) antibody. Figitumumab prevents IGF1 from binding to IGF1R with an IC50 of 1.8 nM .
loading...
    loading...
Cat. No.: HY-18785
CAS No.: 854171-35-0
Target:  

IGF-1R

Research Areas:  

Endocrinology Cancer

Indirubin Derivative E804 is a potent inhibitor of Insulin-like Growth Factor 1 Receptor (IGF1R), with an IC50 of 0.65 μM for IGF1R.
loading...
    loading...
Cat. No.: HY-145110
CAS No.: 1116236-15-7
Purity:  98.36%
Target:  

IGF-1R

Research Areas:  

Cancer

IGF-1R inhibitor-2 (example 121) is an insulin-like growth factor-1 receptor (IGF-1R) inhibitor. Downregulation of IGF-1R can reverse the transformed phenotype of tumor cells and potentially render them susceptible to apoptosis .
loading...
    loading...
Cat. No.: HY-108486
CAS No.: 70563-58-5
Purity:  99%
Herbimycin A is an antibiotic and protein tyrosine kinase inhibitor. Herbimycin A directly inhibits the autophosphorylation of p210 BCR-ABL with an IC50 of approximately 5 μM, and reduces Src kinase activity. Herbimycin A also induces the degradation of receptor tyrosine kinases such as insulin-like growth factor 1 receptor (IGF-1R), insulin receptor (IR) and epidermal growth factor receptor (EGFR) via the ubiquitin-20S proteasome pathway. Herbimycin A directly modifies NF-κB p50, with the main target site involving Cys62, thereby blocking the DNA binding of p50 and NF-κB-driven gene expression. Herbimycin A can be used in studies related to tyrosine kinase signaling, chronic myeloid leukemia, NF-κB signaling, osteoclast function, apoptosis and cellular stress .
loading...
    loading...
Cat. No.: HY-P990084
CAS No.: 2728655-31-8
Synonyms: AVE1642; VRDN-001
Target:  

IGF-1R Akt

Research Areas:  

Neurological Disease Endocrinology

Veligrotug (AVE1642) is a selective, fully human IGF-1R antagonist antibody with a Kd value of 0.55 nM for hIGF-1R. Veligrotug blocks the phosphorylation of downstream AKT. Veligrotug is applicable to research related to thyroid eye disease .
loading...
    loading...
Cat. No.: HY-15494R
CAS No.: 477-47-4
Synonyms: AXL1717 (Standard); Picropodophyllotoxin (Standard); PPP (Standard)
Picropodophyllin (Standard) is the analytical standard of Picropodophyllin. This product is intended for research and analytical applications. Picropodophyllin (AXL1717) is a selective insulin-like growth factor-1 receptor (IGF-1R) inhibitor with an IC50 of 1 nM.
loading...
    loading...
Cat. No.: HY-P99218
CAS No.: 934235-44-6
Synonyms: Sch 717454; 19D12

Target:  

IGF-1R

Research Areas:  

Cancer

Robatumumab (Sch 717454) is an anti-human IGF-1R (insulin-like growth factor receptor-1) antibody. Robatumumab shows anti-tumor activity and anti-proliferative activity to cancer cells. Robatumumab can be used in osteosarcoma and Ewing sarcoma research .
loading...
    loading...
Cat. No.: HY-153485
CAS No.: 2131025-82-4
Synonyms: ISIS 766720; IONIS-GHR-LRx
Research Areas:  

Others

Cimdelirsen is a novel, ligand-conjugated, hepatic-targeted investigative antisense oligonucleotide designed to reduce growth hormone receptor (GHr) synthesis, thereby inhibiting deleterious effects of growth hormone (GH) hypersecretion and reducing circulating insulin-like growth factor-1 (IGF-1) levels in acromegaly patients.
loading...
    loading...